Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Bausch Health Cos Inc (BHC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2024 Q3 | 271,211 | 0.04 | Add 17.70% | <0.01 | $8.16 | $2,213,082 | SEC |
| 2024 Q2 | 230,431 | 0.03 | Buy | 0.03 | $6.97 | $1,606,104 | SEC |
| 2023 Q4 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2023 Q3 | 120,963 | 0.02 | Buy | 0.02 | $8.22 | $994,316 | SEC |
| 2022 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2022 Q3 | 40,298 | 0.01 | Buy | 0.01 | $6.90 | $278,000 | SEC |
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2022 Q1 | 9,828 | <0.01 | $22.89 | $225,000 | SEC | ||
| 2021 Q4 | 9,828 | <0.01 | Reduce 87.42% | 0.02 | $27.57 | $271,000 | SEC |
| 2021 Q3 | 78,120 | 0.02 | Add 1,002.92% | 0.02 | $27.85 | $2,176,000 | SEC |
| 2021 Q2 | 7,083 | <0.01 | Reduce 12.61% | <0.01 | $29.37 | $208,000 | SEC |
| 2021 Q1 | 8,105 | <0.01 | Reduce 23.54% | <0.01 | $31.71 | $257,000 | SEC |
| 2020 Q4 | 10,600 | <0.01 | Reduce 91.87% | 0.04 | $20.75 | $220,000 | SEC |
| 2020 Q3 | 130,361 | 0.04 | Reduce 15.08% | <0.01 | $15.54 | $2,026,000 | SEC |
| 2020 Q2 | 153,517 | 0.06 | Add 0.31% | <0.01 | $18.29 | $2,808,000 | SEC |
| 2020 Q1 | 153,038 | 0.05 | Add 5.69% | <0.01 | $15.50 | $2,372,000 | SEC |
| 2019 Q4 | 144,798 | 0.06 | Reduce 30.42% | 0.02 | $29.92 | $4,332,000 | SEC |
| 2019 Q3 | 208,114 | 0.07 | Reduce 23.96% | 0.02 | $21.85 | $4,547,000 | SEC |
| 2019 Q2 | 273,690 | 0.10 | Reduce 16.43% | 0.02 | $25.22 | $6,903,000 | SEC |
| 2019 Q1 | 327,510 | 0.11 | Add 50.96% | 0.04 | $24.69 | $8,087,000 | SEC |
| 2018 Q4 | 216,950 | 0.06 | Reduce 20.49% | 0.02 | $18.47 | $4,007,000 | SEC |
| 2018 Q3 | 272,870 | 0.09 | Buy | 0.09 | $25.67 | $7,005,000 | SEC |